Search Results - "Faig, Jennifer"

Changing Pattern in Malignant Mesothelioma Survival by Faig, Jennifer, Howard, Suzanne, Levine, Edward A, Casselman, Gary, Hesdorffer, Mary, Ohar, Jill A

“…Abstract Survival for mesothelioma has been shown to be poor, with marginal improvement over time. Recent advances in the understanding of pathophysiology and…”
Get full text

Who Should Discuss Advance Care Planning? A Survey of Preferences Among Hospitalized Patients with Serious Illness (SA518B) by Faig, Jennifer, MD, Buss, Mary, MD, Sokol-Hessner, Lauge, MD, Targan, Elizabeth, MD, Mukamal, Kenneth, MD

“…An abstract of a study by Faig et al determining with which provider seriously ill, hospitalized, non-oncology patients prefer to have advance care planning…”
Get full text

Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung Cancer by Ostios-Garcia, Lorena, Faig, Jennifer, Leonardi, Giulia C, Adeni, Anika E, Subegdjo, Safiya J, Lydon, Christine A, Rangachari, Deepa, Huberman, Mark S, Sehgal, Kartik, Shea, Meghan, VanderLaan, Paul A, Cheng, Matthew P, Marty, Francisco M, Hammond, Sarah P, Costa, Daniel B, Awad, Mark M

“…Despite widespread administration of programmed death receptor 1 (PD-1) pathway inhibitors among individuals with NSCLC, little is known about the safety and…”
Get more information

Improving the survivorship care plan process across an academic and community cancer center by Stuver, Robert, Faig, Jennifer, Abrahamian, Gerry, Cadorette, Matthew M., Decaneas, William M., Kaplan, Irving D., Kent, Michael S., Van De Wege, Christine, Zerillo, Jessica A.

“…Abstract only 184 Background: The goal of a survivorship care plan (SCP) is to improve provider coordination and engage patients in their care. Despite…”
Get full text

Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy by Faig, Jennifer, Haughton, Michael, Taylor, Richard C, D'Agostino, Jr, Ralph B, Whelen, Megan J, Porosnicu Rodriguez, Kori A, Bonomi, Marcelo, Murea, Mariana, Porosnicu, Mercedes

“…Cisplatin remains the pivotal chemotherapy in squamous cell carcinoma of the head and neck (SCCHN), with nephrotoxicity considered the dose-limiting toxicity…”
Get full text

Improving the Medical Orders for Life-Sustaining Treatment (MOLST) form documentation process in an outpatient oncology clinic by Faig, Jennifer, Zerillo, Jessica A., Wright, Danielle, Sato-DiLorenzo, Aya, Mahony, Michelle, Mantia, Charlene, Salazar, Rolando, O'Leary, Carol, Nguyen, Mayca, Buss, Mary K.

“…Abstract only 299 Background: Advance care planning is an important aspect of providing high quality care to oncology patients. ASCO Quality Oncology Practice…”
Get full text

Training Hematologists/Oncologists for the Academic-Community Hybrid: Creating a Fellowship Framework for the Future by Roberts, Daniel A, Faig, Jennifer, Bodio-Downey, Kelly, Shpilsky, Jason, Leahy, Kathleen, Wischhusen, Jonathan, Giordano, Sara, Acharya, Utkarsh, Drews, Reed, Dougherty, David, Lathan, Christopher, Rangachari, Deepa

“…Conventional hematology/oncology fellowship training is designed to foster careers in academic practice through intensive exposure to clinical and laboratory…”
Get more information

Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer by Bychkovsky, Brittany L., Guo, Hao, Sutton, Jazmine, Spring, Laura, Faig, Jennifer, Dagogo‐Jack, Ibiayi, Battelli, Chiara, Houlihan, Mary Jane, Yeh, Tsai‐Chu, Come, Steven E., Lin, Nancy U.

“…Background. Despite guideline recommendations, baseline laboratory testing and advanced imaging are widely ordered in clinical practice to stage asymptomatic…”
Get full text